Correlation Between Le Travenues and Akums Drugs

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Le Travenues and Akums Drugs at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Le Travenues and Akums Drugs into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Le Travenues Technology and Akums Drugs and, you can compare the effects of market volatilities on Le Travenues and Akums Drugs and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Le Travenues with a short position of Akums Drugs. Check out your portfolio center. Please also check ongoing floating volatility patterns of Le Travenues and Akums Drugs.

Diversification Opportunities for Le Travenues and Akums Drugs

0.6
  Correlation Coefficient

Poor diversification

The 3 months correlation between IXIGO and Akums is 0.6. Overlapping area represents the amount of risk that can be diversified away by holding Le Travenues Technology and Akums Drugs and in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Akums Drugs and Le Travenues is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Le Travenues Technology are associated (or correlated) with Akums Drugs. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Akums Drugs has no effect on the direction of Le Travenues i.e., Le Travenues and Akums Drugs go up and down completely randomly.

Pair Corralation between Le Travenues and Akums Drugs

Assuming the 90 days trading horizon Le Travenues Technology is expected to generate 0.58 times more return on investment than Akums Drugs. However, Le Travenues Technology is 1.71 times less risky than Akums Drugs. It trades about -0.07 of its potential returns per unit of risk. Akums Drugs and is currently generating about -0.31 per unit of risk. If you would invest  14,659  in Le Travenues Technology on August 30, 2024 and sell it today you would lose (675.00) from holding Le Travenues Technology or give up 4.6% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Le Travenues Technology  vs.  Akums Drugs and

 Performance 
       Timeline  
Le Travenues Technology 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Le Travenues Technology has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's forward indicators remain very healthy which may send shares a bit higher in December 2024. The recent disarray may also be a sign of long period up-swing for the firm investors.
Akums Drugs 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Akums Drugs and has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in December 2024. The recent disarray may also be a sign of long period up-swing for the firm investors.

Le Travenues and Akums Drugs Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Le Travenues and Akums Drugs

The main advantage of trading using opposite Le Travenues and Akums Drugs positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Le Travenues position performs unexpectedly, Akums Drugs can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Akums Drugs will offset losses from the drop in Akums Drugs' long position.
The idea behind Le Travenues Technology and Akums Drugs and pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.

Other Complementary Tools

Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges